Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;68(11):e29237.
doi: 10.1002/pbc.29237. Epub 2021 Jul 31.

Prevalence of metachronous contralateral mature ovarian teratoma: A systematic review

David Kiely  1 , Carianne Lewis  2 , Juliet Gray  3 , Nigel Hall  3
Affiliations

Prevalence of metachronous contralateral mature ovarian teratoma: A systematic review

David Kiely et al. Pediatr Blood Cancer. 2021 Nov.

Abstract

There is increasing recognition that contralateral metachronous tumor may occur following treatment of unilateral mature ovarian teratoma. We aimed to define this risk to guide appropriate surveillance strategies. We undertook a systematic review of three large medical databases (Ovid Medline, Embase, and Cochrane Controlled Trials Register) to April 2020 using a defined search strategy. From 1831 articles retrieved, 23 were included, reporting 1101 girls with unilateral mature ovarian teratomas. The intensity and duration of follow-up varied between studies, with only five reporting close surveillance. Overall prevalence of metachronous contralateral mature teratoma was 2.1%, with a prevalence per study of 0%-23% (median 0%). Prevalence was higher (7%) among studies with more robust surveillance. These data suggest a small but real risk of metachronous contralateral tumors. Surveillance ultrasonography is proportionate and indicated alongside further prospective data collection to record the natural history and impact of surveillance in greater detail.

Keywords: mature teratoma; ovarian; pediatric; recurrence.

PubMed Disclaimer

References

REFERENCES

    1. Brougham M, Nicholson J, Stoneham S, et al. Interim Guidelines for the Treatment of Extra Cranial Germ Cell Tumours in Children and Adolescents. Children's Cancer and Leukaemia Group; June 2018.
    1. Taskinen S, Urtane A, Fagerholm R, Lohi J, Taskinen M. Metachronous benign ovarian tumors are not uncommon in children. J Pediatr Surg. 2014;49(4):543-545.
    1. Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1.
    1. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration; 2011.
    1. Terenziani M, D'Angelo P, Inserra A, et al. Mature and immature teratoma: a report from the second Italian pediatric study. Pediatr Blood Cancer. 2015;62(7):1202-1208.

Publication types

Supplementary concepts

LinkOut - more resources